Jim Post has a strong record of leading teams and businesses to drive innovation in healthcare. As president of the anatomic pathology business for Thermo Fisher Scientific, Jim spearheaded its turnaround, growth and sale to global healthcare company PHC Holdings Corporation (PHC). He led the integration of the business into PHC as president and CEO of the newly formed entity, Epredia, which he helped position as a global precision cancer diagnostics company focused on improving patient outcomes. Prior to Thermo Fisher, Jim held key management positions with Alere, including president of its global hospital business. Jim began his career in the healthcare instrument business with United States Surgical, where he was promoted to positions of increasing responsibility. He is a graduate of the University of Rochester.